Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529)
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…

The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from
antibody responses, although the extent to which these substitutions in spike and non-spike …

… Kerri J St Denis , Kerri J St Denis … , Julia C Thierauf, Grace Kirkpatrick, Maristela L Onozato,
Ju Cheng, Kerri J St Denis, Evan C Lam, Clarety Kaseke, Rhoda Tano-Menka, Diane Yang, …

Although children have been largely spared from coronavirus disease 2019 (COVID-19), the
emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of …

PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients
with cancer are poorly understood. METHODS We performed a prospective cohort study of …

Patients with cancer are more likely to have impaired immune responses to SARS-CoV-2
vaccines. We study the breadth of responses against SARS-CoV-2 variants after primary …

Protein-based virus-like particles (P-VLPs) are commonly used to spatially organize antigens
and enhance humoral immunity through multivalent antigen display. However, P-VLPs are …

Currently available mRNA vaccines are extremely safe and effective to prevent severe
SARS-CoV-2 infections. However, the emergence of variants of concerns (VOCs) has highlighted …

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals
have resulted in increased infections and hospitalizations. Children are not spared from …

… Saff MD, PhD a b , James MacLean MD h , Onosereme Ofoman BS d , Cristhian Berrios
MD d , Kerri J. St Denis BS i , Evan C. Lam BS i , David Gregory PhD j k , Anthony John Iafrate …